Privat-docent thesis
Open access

Liver transplantation for the treatment of hepatocellular carcinoma

ContributorsToso, Christian
Defense date2010

Liver transplantation is the best treatment option for selected patients with non-resectable hepatocellular carcinoma (HCC). In many centers, patient selection is currently performed according to Milan criteria and allowing transplantation for patients with a single HCC ≤5cm or up to 3 HCCs ≤3cm. The present thesis demonstrates that patients with more advanced HCCs, with total tumor volume ≤115cm3 and alpha-fetoprotein ≤400ng/ml, can also benefit from liver transplantation and have similarly good post-transplant outcomes. Another way of allowing transplantation to patients with more advanced HCC, is to downstage HCCs prior to listing. This option is also discussed. Adjuvant post-transplant management should be performed with the use of sirolimus, an immunosuppression drug with anti-cancer properties. This drug has an appropriate side-effect profile and improves post transplantation survival in patients with HCC. Such strategies will help including more patients for transplantation, with maintained good post-transplant survivals.

  • Transplantation
  • Liver
  • Hepatocellular carcinoma
  • Sirolimus
Citation (ISO format)
TOSO, Christian. Liver transplantation for the treatment of hepatocellular carcinoma. 2010. doi: 10.13097/archive-ouverte/unige:12935
Main files (1)

Technical informations

Creation12/17/2010 5:38:00 PM
First validation12/17/2010 5:38:00 PM
Update time03/14/2023 4:10:38 PM
Status update03/14/2023 4:10:38 PM
Last indexation01/29/2024 7:05:57 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack